New drug targets gene mutation in Hard-to-Treat endometrial cancer
Disease control
Not yet recruiting
This study tests a drug called Inavolisib in about 48 women with advanced endometrial cancer that has a specific change in the PIK3CA gene. The goal is to see if the drug can shrink tumors or slow the cancer's growth. Participants will take the drug and be monitored for response …
Phase: PHASE2 • Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC